Procyon Corp. is a holding company, which engages in the development and marketing of skin and wound care products. The company is headquartered in Clearwater, Florida and currently employs 19 full-time employees. AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a proprietary line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.
Follow-Up Questions
What is Procyon Corp (PCYN)'s P/E Ratio?
The P/E ratio of Procyon Corp is N/A
Who is the CEO of Procyon Corp?
Mr. Justice Anderson is the Chief Executive Officer of Procyon Corp, joining the firm since 2005.
What is the price performance of PCYN stock?
The current price of PCYN is 0.102, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Procyon Corp?
Procyon Corp belongs to Health Care industry and the sector is Health Care
What is Procyon Corp market cap?
Procyon Corp's current market cap is $828.2
Is Procyon Corp a buy, sell, or hold?
According to wall street analysts, 0 analysts have made analyst ratings for Procyon Corp, including 0 strong buy, 0 buy, 0 hold, 0 sell, and 0 strong sell
